Results 141 to 150 of about 408,139 (189)

Fibrosis peritoneal

La diálisis peritoneal (DP) es una de las formas de sustitución de la función renal y como tratamiento abarca a más de 100.000 pacientes con insuficiencia renal crónica estadio V en todo el mundo, por lo que la tasa de prevalencia abarca entre el 10 y el
Trevisani, Horacio Alfredo
core  

Intraperitoneal enalapril ameliorates morphologic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum.

, 2004
Peritoneal fibrosis (PF) is one of the most serious causes of technique failure in long-term peritoneal dialysis (PD). Although the mechanisms responsible for the genesis of PF are not well understood, angiotensin II is known to promote fibrosis and ...
Duman S., Kwiatkowska B., Styszynski A., Oreopoulos D.G., Wieczorowska-Tobis K., Breborowicz A.   +5 more
core  

Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis. [PDF]

Pharmaceuticals (Basel)
Li YC, Hsu JT, Fu CM, Liu TC, Lee YT, Wu PJ, Li LC, Chiou TT, Chiu CH, Kuo WH, Huang CC, Tsai KF, Hsu TW, Lee WC, Lee CT, Yang CC.   +15 more
europepmc   +1 more source

The Role of NF-κB in Peritoneal Fibrosis and Adhesion in Humans and Animals: A Systematic Review. [PDF]

Int J Mol Sci
Jasiński T, Kozłowska N, Zdrojkowski Ł, Bręborowicz A, Rey B, Domino M.   +5 more
europepmc   +1 more source

L-Glutamine attenuates peritoneal fibrosis developed in 5-Fluorouracil-treated mice. [PDF]

Exp Biol Med (Maywood)
Heleno JFG, Dos Santos LCC, Fontes IC, Paiva Silva MRA, Correia LB, Silva NDG, Prazeres PHDM, Goulart Guimarães PP, Gilroy DW, Andrade SP, Campos PP.   +10 more
europepmc   +1 more source

Research progress on histone deacetylases in peritoneal dialysis-associated peritoneal fibrosis. [PDF]

Ren Fail
Qiu W, Chen J, Behera TR, Huang Y, Chu C, Xu B, Shen Q, Yan J.   +7 more
europepmc   +1 more source

Astragaloside IV attenuates high-glucose-Induced peritoneal fibrosis via modulation of the ENKUR/PI3K/Akt signalling pathway. [PDF]

PLoS One
Jiang T, Zhang L, Liu J, Xu X, Shi Y, Zhao Z, Xiao J.   +6 more
europepmc   +1 more source

Pericyte-myofibroblast transition: a novel mechanism in peritoneal fibrosis and the effect of Asiaticoside. [PDF]

J Adv Res
Shi J, Tang L, You Y, Yu M, Shan Y, Zhu X, Zheng Y, Sheng M.   +7 more
europepmc   +1 more source

Correction: The disruptor of telomeric silencing 1-like (DOT1L) promotes peritoneal fibrosis through the upregulation and activation of protein tyrosine kinases. [PDF]

Mol Biomed
Tao M, Shi Y, Chen H, Li J, Wang Y, Ma X, Du L, Wang Y, Yang X, Hu Y, Zhou X, Zhong Q, Yan D, Qiu A, Zhuang S, Liu N.   +15 more
europepmc   +1 more source

EXPRESSION OF CONCERN: Nintedanib Attenuates Peritoneal Fibrosis by Inhibiting Mesothelial-to-Mesenchymal Transition, Inflammation and Angiogenesis. [PDF]

J Cell Mol Med
europepmc   +1 more source